<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>XM-DAC-41114-OUTPUT-00127276</iati-identifier>
  <reporting-org ref="XM-DAC-41114" type="40">
   <narrative xml:lang="EN">United Nations Development Programme</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">HIV MAL &amp; TB NFM3 BENGUELA CUA</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The Project seeks to establish a robust integrated HIV/Malaria and TB system and response in the provinces of Benguela and Cuanza Sul, while ensuring that the approaches adopted are compatible with the national health system.</narrative>
  </description>
  <participating-org ref="XM-DAC-47045" role="1">
   <narrative xml:lang="EN">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41114" role="4" type="40">
   <narrative xml:lang="EN">United Nations Development Programme</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-07-01" type="1"></activity-date>
  <activity-date iso-date="2021-07-01" type="2"></activity-date>
  <activity-date iso-date="2024-06-30" type="3"></activity-date>
  <contact-info type="1">
   <email>registry.ao@undp.org</email>
   <website>http://www.ao.undp.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="AO" percentage="100">
   <narrative xml:lang="EN">Angola</narrative>
  </recipient-country>
  <location ref="AO">
   <location-reach code="1"></location-reach>
   <location-id code="2240449" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">Luanda</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">capital of a political entity</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">Project implementation office</narrative>
   </activity-description>
   <administrative code="2240449" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-8.836820 13.234320</pos>
   </point>
   <exactness code="1"></exactness>
   <location-class code="2"></location-class>
   <feature-designation code="PPLC"></feature-designation>
  </location>
  <sector code="17" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Eradicate poverty in all its forms and dimensions</narrative>
  </sector>
  <sector code="16050" percentage="100" vocabulary="1"></sector>
  <sector code="3.3" percentage="100" vocabulary="8"></sector>
  <tag code="3.3" vocabulary="3"></tag>
  <policy-marker code="1" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="4"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-12-31">23114931</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-05-31">7775374</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">82600349</value>
   <provider-org ref="XM-DAC-47045">
    <narrative xml:lang="EN">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00127276" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">23114931</value>
   <provider-org ref="XM-DAC-47045">
    <narrative xml:lang="EN">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00127276" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">7775374</value>
   <provider-org ref="XM-DAC-47045">
    <narrative xml:lang="EN">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00127276" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-30"></transaction-date>
   <value currency="USD" value-date="2021-11-30">289534</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <receiver-org type="10">
    <narrative xml:lang="EN">Government of Angola</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">1073018</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <receiver-org type="10">
    <narrative xml:lang="EN">Government of Angola</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">280756</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <receiver-org type="10">
    <narrative xml:lang="EN">Government of Angola</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-07-31"></transaction-date>
   <value currency="USD" value-date="2021-07-31">83699</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-08-31"></transaction-date>
   <value currency="USD" value-date="2021-08-31">145531</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">938308</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-10-31"></transaction-date>
   <value currency="USD" value-date="2021-10-31">1706848</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-11-30"></transaction-date>
   <value currency="USD" value-date="2021-11-30">306771</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">1147605</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-01-31"></transaction-date>
   <value currency="USD" value-date="2022-01-31">4074982</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-02-28"></transaction-date>
   <value currency="USD" value-date="2022-02-28">687188</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-03-31"></transaction-date>
   <value currency="USD" value-date="2022-03-31">1344489</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-04-30"></transaction-date>
   <value currency="USD" value-date="2022-04-30">-39657</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">13466688</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">2093680</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-06-27"></transaction-date>
   <value currency="USD" value-date="2022-06-27">425252</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <document-link format="TEXT/HTML" url="http://open.undp.org/projects/00136333">
   <title>
    <narrative xml:lang="EN">Activity web page</narrative>
   </title>
   <category code="A12"></category>
  </document-link>
  <related-activity ref="XM-DAC-41114-OUTPUT-00128834" type="3"></related-activity>
  <related-activity ref="XM-DAC-41114-PROJECT-00136333" type="1"></related-activity>
  <conditions attached="1">
   <condition type="1">
    <narrative xml:lang="EN">Social and environmental sustainability will be enhanced through application of the UNDP Social and Environmental Standards (http://www.undp.org/ses) and related Accountability Mechanism (http://www.undp.org/secu-srm).</narrative>
   </condition>
   <condition type="1">
    <narrative xml:lang="EN">UNDP as the Implementing Partner will comply with the policies, procedures and practices of the United Nations Security Management System (UNSMS.)</narrative>
   </condition>
  </conditions>
  <result aggregation-status="1" type="1">
   <title>
    <narrative xml:lang="EN">Annual Output Results</narrative>
   </title>
   <indicator ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">Output Indicator</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">HIV
I - PMTCT-2.1 Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery 
II - KP-1a??? Percentage of men who have sex with men reached with HIV prevention programs - defined package of services 
I II - YP-1b Percentage of young people aged 10&#x2013;24 years reached by comprehensive sexuality education and/or life skills&#x2013;based HIV education out of schools 
IV - TCS-1.1??? Percentage of people on ART among all people living with HIV at the end of the reporting period 

Tuberculosis
V - TB/HIV-6??? Percentage of HIV-positive new and relapse TB patients on ART during TB treatment 
VI - TCP-1??? Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases 
VII - TCP-2??? Treatment success rate- all forms: Percentage of TB cases, all forms bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus - treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases 

Malaria
VIII - CM-1a??? Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities 
IX - CM-2a??? Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities
X - SPI-1 Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
    </description>
    <baseline year="2021">
     <comment>
      <narrative xml:lang="EN">HIV
I - PMTCT-2.1 Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery - 1.507 / 4.105 = 36,71% (2019)
II - KP-1a??? Percentage of men who have sex with men reached with HIV prevention programs - defined package of services - 686 / 6.420 = 10,69% (2019)
III - YP-1b Percentage of young people aged 10&#x2013;24 years reached by comprehensive sexuality education and/or life skills&#x2013;based HIV education out of schools - 25.263 / 859.243 = 2,94% (2019).
IV - TCS-1.1??? Percentage of people on ART among all people living with HIV at the end of the reporting period - 93.300 / 340.000 = 27,44% (2019)

Tuberculosis
V - TB/HIV-6??? Percentage of HIV-positive new and relapse TB patients on ART during TB treatment - 
VI - TCP-1??? Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases - 13.613 (2019)
VII - TCP-2??? Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases - 60,00% (2019)

Malaria
VIII - CM-1a??? Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities - 2.124.803 / 2.257.131 = 94,14% (2019)
IX - CM-2a??? Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities - 965.543 / 1.093.124 = 88,33%
X - SPI-1 Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria - 221.954 / 1.018.055 = 21,80% (2019)</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">HIV
I - PMTCT-2.1 Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery - 1.239 / 4.346 = 28,50%
II - KP- Percentage of men who have sex with men reached with HIV prevention programs - defined package of services - 1.082 / 7.210 = 15,00%
I II - YP-1b Percentage of young people aged 10&#x2013;24 years reached by comprehensive sexuality education and/or life skills&#x2013;based HIV education out of schools - 21.008 / 350.140 = 6,00%.
IV - TCS-Percentage of people on ART among all people living with HIV at the end of the reporting period - 126.350 / 361.000 = 35,00%.

Tuberculosis
V - TB/HIV-6&#x207D;&#x1D39;&#x207E; Percentage of HIV-positive new and relapse TB patients on ART during TB treatment - 495 / 619 = 80,00%
VI - TCP-1&#x207D;&#x1D39;&#x207E; Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases - 7.808
VII - TCP-2&#x207D;&#x1D39;&#x207E; Treatment success rate- all forms: Percentage of TB cases, all forms bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus - treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases - 5.105 / 6.807 = 75,00%

Malaria
VIII - CM-1a&#x207D;&#x1D39;&#x207E; Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities - 100%
IX - CM-2a&#x207D;&#x1D39;&#x207E; Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities - 95,00%
X - SPI-1 Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria - 41.089 / 102.724 = 40,00%</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">HIV
I - PMTCT-2.1 Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery - 16.2% (702 / 4,346)
II - KP-1a Percentage of men who have sex with men reached with HIV prevention programs - defined package of services - 16.48% (1,188 / 7,210)
III - YP-1b Percentage of young people aged 10&#x2013;24 years reached by comprehensive sexuality education and/or life skills&#x2013;based HIV education out of schools - 2.9% (10,053 / 350,140)
IV - TCS-Percentage of people on ART among all people living with HIV at the end of the reporting period - 41.8% (150,750 / 361,000)

Tuberculosis
V - TB/HIV-6&#x207D;&#x1D39;&#x207E; Percentage of HIV-positive new and relapse TB patients on ART during TB treatment - 11.8% (35 / 296)
VI - TCP-1&#x207D;&#x1D39;&#x207E; Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases - 82.4% (6,434 / 7,808) 
VII - TCP-2&#x207D;&#x1D39;&#x207E; Treatment success rate- all forms: Percentage of TB cases, all forms bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus - treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases - 88.2% (6,142 / 6,963)

Malaria
VIII - CM-1a&#x207D;&#x1D39;&#x207E; Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities - 92.7% (1,049,380 / 1,132,386) 
IX - CM-2a&#x207D;&#x1D39;&#x207E; Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities - 56.3% (318,741 / 566,525)
X - SPI-1 Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria - 33.6% (26,832 / 79,927)</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">I - PMTCT-2.1 Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery - 28.5% (1,239 / 4,346)
II - KP-1a Percentage of men who have sex with men reached with HIV prevention programs - defined package of services - 15% (1,082 / 7,210)
III - YP-1b Percentage of young people aged 10&#x2013;24 years reached by comprehensive sexuality education and/or life skills&#x2013;based HIV education out of schools - 7.0% (24,510 / 350,140)
IV - TCS-Percentage of people on ART among all people living with HIV at the end of the reporting period - 40% (144,400 / 361,000)

Tuberculosis
V - TB/HIV-6&#x207D;&#x1D39;&#x207E; Percentage of HIV-positive new and relapse TB patients on ART during TB treatment - 495 (80%) out of 619
VI - TCP-1&#x207D;&#x1D39;&#x207E; Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases - 7,808
VII - TCP-2&#x207D;&#x1D39;&#x207E; Treatment success rate- all forms: Percentage of TB cases, all forms bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus - treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases - 75.0% (5,105 / 6,807)

Malaria
VIII - CM-1a&#x207D;&#x1D39;&#x207E; Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities - 100% 
IX - CM-2a&#x207D;&#x1D39;&#x207E; Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities &#x2013; 95%
X - SPI-1 Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria - 40% (52,296 / 130,739).</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Results will be available in December 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
